The latest LifeSci SPAC said it is targeting companies in North America or Europe that are developing assets in the biopharma, medical technology, digital health, and healthcare services sectors. Read more.
LifeSci II Amends Prospectus on $75M IPO
Related Posts
Vickers Vantage I Sponsor Pumps $1M into Trust for Deadline Extension
If the SPAC completes an initial business combination, it may choose to repay the sponsor's loan or convert some portion or all of the total loan amount into warrants.
Gaming & Hospitality Acquisition Completes Upsized $200M IPO
The SPAC will focus on regional gaming, distributed gaming, online gaming / sports betting and gaming technology and equipment.
Feutune Light Acquisition Files Proxy on Deal with EV Maker Thunder Power
Terms call for closing merger consideration of $400 million in stock, plus $200 million in earnout shares, subject to a vesting timetable.
FG Merger Files for $70M IPO
The fintech-focused SPAC will target North American companies.